Evolus Launches Nuceiva® (botulinum toxin type A) in It

Launching in the fourth largest aesthetic toxin injectables market in Europe1 is part of the company’s geographic expansion strategy



GP Dermal Solution will serve as distribution partner in Italy

Related Keywords

Germany , Austria , United Kingdom , Italy , Canada , Rome , Lazio , United States , Italian , Great Britain , Dan Stewart , Joely Kaufman Janette , Erminio Mastroluca , Berthold Josef Rzany , David Moatazedi , Z Paul Lorenc , European Commission , Nasdaq , Exchange Commission On , Decision Research Group , Daewoong Pharmaceutical Co Ltd , Exchange Commission , Allergan Inc , Linkedin , Evolus International , Twitter , Evolus Inc , Vice President , General Manager , Private Securities Litigation Reform Act , Medytox Settlement Agreements , Annual Report , Quarterly Report , Research Group , Aesthetic Injectables Market Insights , Injectables Tracker , Josef Rzany , Surgery Journal , Markets ,